Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
Guocheng Huang, Maria Areli Lorenzana Carrillo, Hua Chen, Runtai Chen, Saba Abbasi Dezfouli, Joseph Nanoa, Dania Rimawi, Alois Haromy, Yuanyuan Zhao, Rohan Mittal, John Lewis, John R. Ussher, Evangelos D. Michelakis, Ronald Moore, Seyed Amirhossein Tabatabaei Dakhili, , Adam Kinnaird
This study identifies ZNF281 as a driver of metastatic prostate cancer and shows that targeting it with a novel inhibitor suppresses tumor growth and metastasis in multiple models.
bioRxiv · Sep 7, 2026 · PreprintCancer Biology